ChemotherapyApproved for: NSCLC, SCLC Methotrexate Sodium (Trexall/ Xatmep) Related Research News Pre- and Post-surgical Immunotherapy-based Treatment Significantly Improved Lung Cancer OutcomesLong-term study reveals ‘ever-changing’ nature of lung cancerLung Cancer Trial Has Broader Eligibility Criteria, Overcomes Barriers
ChemotherapyApproved for: NSCLC, SCLC Etoposide is a FDA-approved Chemotherapy for non-small cell lung cancer (NSCLC) that is metastatic or small cell lung cancer (SCLC) that is metastatic. Related Research News Lack of Adherence to Treatment Guidelines in NSCLCImmunotherapy +
...
ChemotherapyApproved for: SCLC Etoposide is a FDA-approved Chemotherapy for small cell lung cancer (SCLC). Related Research News Pre- and Post-surgical Immunotherapy-based Treatment Significantly Improved Lung Cancer OutcomesLong-term study reveals ‘ever-changing’ nature of lung cancerLung Cancer Trial Has Broader Eligibility
...
ChemotherapyApproved for: NSCLC Gemcitabine Hydrochloride (Gemzar/ Infugem) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or metastatic and cannot be removed by surgery. It is used with cisplatin. Related Research News Pre- and Post-surgical Immunotherapy-based
...
ChemotherapyApproved for: NSCLC, SCLC Carboplatin + paclitaxel (carbo taxol) is given to shrink tumors and improve symptoms of lung cancer. If the disease is not metastatic (spread to areas of the body outside the lungs), carboplatin + paclitaxel may
...
ChemotherapyApproved for: NSCLC Docetaxel (Taxotere) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or has metastasized. It is used: Alone in patients whose cancer has not gotten better after platinum chemotherapy With cisplatin in patients whose
...
ChemotherapyApproved for: NSCLCBiomarker: test Bevacizumab (Avastin/Mvasi/Zirabev) approved Chemotherapy for Nonsquamous non-small cell lung cancer (NSCLC) that is locally advanced, cannot be removed by surgery, has metastasized, or has recurred. It is used with carboplatin and paclitaxel as first-line therapy.
...
ChemotherapyApproved for: NSCLC Paclitaxel Albumin-Stabilized Nanoparticle Formulation (Abraxane) approved Chemotherapy for Non-small cell lung cancer (NSCLC) that is locally advanced or has metastasized. It is used with carboplatin as first-line treatment in patients whose disease cannot be treated with surgery
...
ChemotherapyApproved for: NSCLC Necitumumab (Portrazza) is a FDA-approved Chemotherapy for Squamous non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment. Related Research News Pre- and Post-surgical Immunotherapy-based
...
ChemotherapyApproved for: SCLC Lurbinectedin was approved for Small Cell Lung Cancer (SCLC) that is metastatic. It is used in adults whose disease has gotten worse during or after treatment with platinum chemotherapy. This use is approved under FDA’s Accelerated
...